• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

PwC Report: 5 Key Actions for Pharma Companies to Drive Value Growth

by Jasmine Pennic 06/03/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
PwC Report: 5 Key Actions for Pharma Companies to Drive Value Growth

What You Should Know:

– A new PwC report offers insights into how pharma companies can translate game-changing science into greater returns.

– Despite many major therapeutic advancements within the last decade, returns from pharma companies lagged the S&P 500 by about one-third and biotech underperformed by 60 percent. The stock performance divide between the front and back of the pack has been widening. PwC’s analysis showed that in 2021, the five-year total shareholder return for drugmakers in the top quintile was up by 29%, compared with a decline of 11% in the bottom quintile.

Key Actions for Pharma Leaders to Drive Value Growth

According to the report, leaders can gain a competitive advantage in the pursuit of higher shareholder returns by focusing on five key actions to drive value growth:

– Build differentiated capabilities (i.e. decentralized trials, machine learning at scale, digital innovation, etc.) to outperform the competition.

– Drive more returns from large IT and cloud investments – Capitalize on investments in AI, automation, and cloud to improve patient/customer satisfaction and efficiency.

– Retain talent and prioritize culture – In the age of ‘The Great Resignation’ and the ‘war for talent,’ having a differentiated culture is critical. Own ESG responsibilities, nurture a sense of belonging and trust, and create a culture rooted in innovation.

– Think broadly about portfolio and transactions –Given the competitive landscape and abundance of capital in the sector lately, revamp the business development process to drive more outcomes from your transactions.

– Protect the enterprise — Minimize any downside risk around cybersecurity, regulatory challenges, and legal matters to preserve value.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Biotech, cloud, Cybersecurity, digital innovation, Machine Learning, Pharma, PWC Report, risk

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |